50岁及以上急性蛛网膜外硬膜下血肿:当硬膜下血肿表现似硬膜外血肿时
本研究将无蛛网膜下腔出血或其他颅内损伤的蛛网膜外硬膜下血肿前瞻性队列与TRACK-TBI中仅硬膜下血肿对照组比较,经逆概率加权和有序回归分析,蛛网膜外组2周扩展格拉斯哥结局量表评分更优的比值比为5.68(P<0.001),死亡率10%低于CRASH模型预测的21%。作者认为神经外科医生应考虑对此类患者行手术治疗,即使神经查体差、高龄、血肿量大且中线移位明显。
要点
- 蛛网膜外硬膜下血肿患者2周扩展格拉斯哥结局量表评分更优的比值比为5.68(P<0.001)。
- 蛛网膜外硬膜下血肿组死亡率为10%,低于CRASH模型预测的21%。
- 作者认为即使神经查体差、高龄、血肿量大且中线移位明显,也应考虑手术治疗。
核心结论
- 蛛网膜外硬膜下血肿患者2周神经功能结局显著优于对照组,死亡率低于CRASH模型预测值。
- 作者认为神经外科医生应考虑对此类患者行手术治疗,即使神经查体差、高龄、血肿量大且中线移位明显。
研究设计与样本
- 前瞻性蛛网膜外硬膜下血肿系列(无蛛网膜下腔出血或其他伴随颅内损伤)与TRACK-TBI中仅硬膜下血肿对照组比较。
- 对关键特征行逆概率加权,并采用有序回归分析(控制与不控制中线移位)比较2周扩展格拉斯哥结局量表评分。
- 使用CRASH预后模型基于年龄、格拉斯哥昏迷量表评分、瞳孔反应性和主要颅外损伤预测死亡率。
主要发现
- 蛛网膜外硬膜下血肿组与对照组平均中线移位分别为7.2 mm与2.7 mm(P<0.001)。
- 对分组加权并控制中线移位后,蛛网膜外硬膜下血肿患者2周扩展格拉斯哥结局量表评分更优的比值比为5.68(P<0.001)。
- 蛛网膜外硬膜下血肿组死亡率为10%,CRASH模型预测为21%。
临床怎么用
- 作者认为神经外科医生应考虑对此类患者亚组行手术治疗,即使神经查体差、高龄、血肿量大且中线移位明显。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some patients with subdural hematoma (SDH) with acute extra-arachnoid lesions and without concomitant subarachnoid blood or contusions may present in similarly grave neurological condition compared with the general population of patients with SDH. However, these patients often make an impressive neurological recovery. This study compared neurological outcomes in patients with extra-arachnoid SDH with all other SDH patients. METHODS: We compared a prospective series of extra-arachnoid SDH patients without subarachnoid hemorrhage or other concomitant intracranial injury with a Transforming Research and Clinical Knowledge in TBI control group with SDH only. We performed inverse probability weighting for key characteristics and ordinal regression with and without controlling for midline shift comparing neurological outcomes (Extended Glasgow Outcome Scale score) at 2 weeks. We used the Corticosteroid Randomization After Significant Head Injury prognostic model to predict mortality based on age, Glasgow Coma Scale score, pupil reactivity, and major extracranial injury. RESULTS: Mean midline shift was significantly different between extra-arachnoid SDH and control groups (7.2 mm vs. 2.7 mm, P < 0.001). After weighting for group allocation and controlling for midline shift, extra-arachnoid SDH patients had 5.68 greater odds (P < 0.001) of a better 2-week Extended Glasgow Outcome Scale score than control patients. Mortality in the extra-arachnoid SDH group was less than predicted by the Corticosteroid Randomization After Significant Head Injury prognostic model (10% vs. 21% predicted). CONCLUSIONS: Patients with extra-arachnoid SDH have significantly better 2-week neurological outcomes and lower mortality than predicted by the Corticosteroid Randomization After Significant Head Injury model. Neurosurgeons should consider surgery for this patient subset even in cases of poor neurological examination, older age, and large hematoma with high degree of midline shift.
引用
- Eaton JC, Meyer RM, Lim DH, et al. Acute Extra-Arachnoid Subdural Hematomas in Patients 50 Years and Older: When Subdurals Act Like Epidurals. World Neurosurg. 2023. PMID: 37683917. doi:10.1016/j.wneu.2023.08.134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。